Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Fortress Biotech, Inc. | tm205350d1_ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Fortress Biotech, Inc. | tm205350d1_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Fortress Biotech, Inc. | tm205350d1_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Fortress Biotech, Inc. | tm205350d1_ex31-1.htm |
| EX-21.1 - EXHIBIT 21.1 - Fortress Biotech, Inc. | tm205350d1_ex21-1.htm |
| EX-4.3 - EXHIBIT 4.3 - Fortress Biotech, Inc. | tm205350d1_ex4-3.htm |
| 10-K - FORM 10-K - Fortress Biotech, Inc. | tm205350d1_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Fortress Biotech, Inc.
New York, New York
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-226089) and Form S-8 (Nos. 333-184616, 333-194588, 333-20664, 333-221458 and 333-233195) of Fortress Biotech, Inc. of our reports dated March 16, 2020 relating to the consolidated financial statements and the effectiveness of Fortress Biotech, Inc.’s internal control over financial reporting, which appear in this Annual Report on Form 10-K.
/s/ BDO USA, LLP
Boston, Massachusetts
March 16, 2020